Genéricos

Genéricos, often referred to as generic drugs, are pharmaceutical products that are equivalent to brand-name drugs in dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use. They are typically developed after the patent protection for a brand-name drug expires. The active ingredient in a generic drug is the same as in the brand-name drug, meaning it produces the same therapeutic effect.

The development and approval process for generic drugs is overseen by regulatory agencies like the U.S. Food and Drug Administration (FDA). These agencies require generic manufacturers to demonstrate that their product is bioequivalent to the brand-name drug, meaning it is absorbed into the body at the same rate and to the same extent. This ensures that the generic drug will have the same benefits and risks as its branded counterpart.

A significant advantage of generic drugs is their lower cost. Because generic manufacturers do not have to incur the extensive research and development expenses associated with creating a new drug, they can often offer their products at a substantially reduced price. This affordability can improve access to necessary medications for a wider population, contributing to healthcare cost savings.

While the active ingredients are identical, generic drugs may differ in their inactive ingredients, such as fillers, binders, and dyes. These inactive ingredients do not affect the drug's safety, efficacy, or performance. The packaging and trade names of generic drugs are also distinct from their brand-name counterparts. The availability of generic options plays a crucial role in making healthcare more accessible and economical.